Literature DB >> 16844354

Macrolide resistance can be transferred by conjugation from viridans streptococci to Streptococcus pyogenes.

Maria Jönsson1, Göte Swedberg.   

Abstract

Efflux pumps encoded by mef genes are among the most common mechanisms of resistance to macrolides. These genes are often located on horizontally transferable elements such as transposons. We present data indicating conjugative transfer of the mef(E) gene from viridans streptococci to the pathogen Streptococcus pyogenes. The mef(E) gene is located on the previously described MEGA (macrolide efflux genetic assembly) element. Of 110 isolates tested, 85% of those that carried the mef(A/E) gene carried it on MEGA, and in all cases of conjugal transfer of the mef(E) gene it was carried on MEGA. It therefore appears reasonable to draw the conclusion that this element is important in the lateral transfer of macrolide resistance between streptococci.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16844354     DOI: 10.1016/j.ijantimicag.2006.02.023

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  4 in total

Review 1.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

2.  Marine sediment bacteria harbor antibiotic resistance genes highly similar to those found in human pathogens.

Authors:  Jing Yang; Chao Wang; Chang Shu; Li Liu; Jianing Geng; Songnian Hu; Jie Feng
Journal:  Microb Ecol       Date:  2013-02-01       Impact factor: 4.552

3.  Resistance Genes and Genetic Elements Associated with Antibiotic Resistance in Clinical and Commensal Isolates of Streptococcus salivarius.

Authors:  Fanny Chaffanel; Florence Charron-Bourgoin; Virginie Libante; Nathalie Leblond-Bourget; Sophie Payot
Journal:  Appl Environ Microbiol       Date:  2015-04-10       Impact factor: 4.792

4.  Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial.

Authors:  Lorenzo Aguilar; María-José Giménez; José Barberán
Journal:  Infect Drug Resist       Date:  2010-06-18       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.